Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms
DOI:
https://doi.org/10.62438/tunismed.v104i07.6678Abstract
no
Downloads
References
Machnikowska-Sokołowska M, Myszczuk A, Wieszała E, Wieja- Błach D, Jamroz E, Paprocka J. Mucopolysaccharidosis type 1 among
children—neuroradiological perspective based on single centre experience and literature review. Metabolites. 2023;13(2):209.
Grant N, Taylor JM, Plummer Z, Myers K, Burrow T, Luchtman-Jones L. Cerebral revascularization in a child with mucopolysaccharidosis
type I. Front Pediatr. 2021;9:606905.
Olgaç A, Tümer L, Damar Ç, Hasanoğlu A, Ezgü F. Acute stroke in a patient with mucopolysaccharidosis type I with increased carotid
intima-media thickness. EJMO. 2018;2(2):114–6.
BraunlinEA,HarmatzPR,ScarpaM,FurlanettoB, KampmannC,Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis:
presentation, diagnosis, and management. J Inherit Metab Dis. 2011;34:1183–1197.
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for
Moyamoya disease. J Neurosurg. 2009;111:927–935.
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2026 La Tunisie Médicale

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.